Subscribe To

Price Alert Latest News Economic Calendar News

NUS / Nu Skin stock falls 9% after Q4 sales miss

Shares of Nu Skin Enterprises Inc. NUS, +4.76% dropped more than 9% in the extended session Wednesday after the multilevel marketing company reported mixed fourth-quarter results, beating Wall Street expectations for profit but missing on sales, and guidance also disappointed. Nu Skin earned $57.2 million, or $1.15 a share, in the quarter, swinging from a loss of $9.2 million, or 18 cents a share, in the year-ago quarter. Read More

Demo Live Account See Partner Details

Content Topics

Skin

Stock

Falls

After

Sales

Miss

NUS

Posted: Feb 15 2023, 17:48

Author Name: Market Watch

NUS News

By Seeking Alpha
November 1, 2023

Nu Skin Enterprises, Inc. (NUS) Q3 2023 Earnings Call Transcript

Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Scott Pond – Vice President-

By Zacks Investment Research
October 30, 2023

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i

By Zacks Investment Research
October 10, 2023

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

Nu Skin (NUS) is on track with its Nu Vision 2025 strategy. However, the company is operating amid macroeconomic hurdles.

By PRNewsWire
October 3, 2023

Nu Skin Enterprises to Announce Third Quarter 2023 Financial Results

PROVO, Utah , Oct. 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2023 results after the

By Zacks Investment Research
September 21, 2023

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movemen

By Seeking Alpha
September 12, 2023

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance f

By Zacks Investment Research
September 6, 2023

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.

By Zacks Investment Research
August 29, 2023

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consum

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.